Slash Your Medication Costs: The Solution for Affordable Ozempic, Wegovy, Mounjaro, and Rybelsus

The disparity in prescription drug costs between the United States and Canada is a well-documented phenomenon, primarily driven by Canada's different approach to pharmaceutical pricing. The Canadian government, through agencies like the Patented Medicine Prices Review Board (PMPRB), actively negotiates with pharmaceutical companies to regulate the prices of patented medicines. This systemic difference creates a significantly lower price ceiling for many brand-name drugs compared to the U.S. market.